Abstract:Background Pencil beam scanning (PBS) proton therapy for moving targets is known to be impacted by interplay effects between the scanning beam and organ motion. While respiratory motion in the thoracic region is the major cause for organ motion, interplay effects depend on the delivery characteristics of proton accelerators. Purpose To evaluate the impact of different types of PBS proton accelerators and spot sizes on interplay effects, mitigations, and plan quality for Stereotactic Body Radiation Therapy (SBRT) treatment of non‐small cell lung cancer (NSCLC). Methods Twenty NSCLC patients treated with photon SBRT were selected to represent varying tumor volumes and respiratory motion amplitudes (median: 0.6 cm with abdominal compression) for this retrospective study. For each patient, plans were created using: (1) cyclotron‐generated proton beams (CPB) with spot sizes of σ = 2.7–7.0 mm; (2) linear accelerator proton beams (LPB) (σ = 2.9–5.5 mm); and (3) linear accelerator proton minibeams (LPMB) (σ = 0.9–3.9 mm). The energy switching time is one second for CPB, and 0.005 s for LPMB and LPB. Plans were robustly optimized on the gross tumor volume (GTV) using each individual phase of four‐dimensional computed tomography (4DCT) scans. Initially, single‐field optimization (SFO) plans were evaluated; if the plan quality did not meet the dosimetric requirement, multi‐field optimization (MFO) was used. MFO plans were created for all patients for comparisons. For each patient, all plans were normalized to have the same dose received by 99% of the GTV. Interplay effects were evaluated by computing the dose on 10 breathing phases, based on the spot distribution. Volumetric repainting (VR) was performed 2–6 times for each plan. We compared volume receiving 100% of the prescribed dose (V100%RX) of the GTV, and normal lung V20Gy. Results Twelve of 20 plans can be optimized sufficiently with SFO. SFO plans were less sensitive to the interplay effect compared to MFO plans in terms of target coverage for both LPB and LPMB. The following comparisons showed results utilizing the MFO technique. In the interplay evaluation without repainting, the mean V100%RX of the GTV were 99.42 ± 0.6%, 97.52 ± 3.9%, and 94.49 ± 7.3% for CPB, LPB, and LPMB plans, respectively. Following VR (2 × for CPB; 3 × for LPB; 5 × for LPMB), V100%RX of the GTV were improved (on average) by 0.13%, 1.84%, and 4.63%, respectively, achieving the acceptance criteria of V100%RX > 95%. Because of fast energy switch in linear accelerator proton machines, the delivery time for VR plans was the lowest for LPB plans, while delivery time for LPMB was on average 1 min longer than CPB plans. The advantage of small spot machines was better sparing in normal lung V20Gy, even when VR was applied. Conclusion In the absence of repainting, proton machines with large spot sizes generated more robust plans against interplay effects. The number of VR increased with decreasing spot sizes to achieve the acceptance criteria. VR improved the plan robustness against interplay effects for modalities with small spot sizes and fast energy changes, preserving the low dose sparing aspect of the LPMB, even when motion is included.

Clinical association between plan complexity and the local-recurrence-free-survival of non-small-cell lung cancer patients receiving stereotactic body radiation therapy

[Prognosis Analysis of Early-stage Non-small Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy]

Dose differences in intensity-modulated radiotherapy plans calculated with pencil beam and Monte Carlo for lung SBRT

Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer

Incorporating plan complexity into the statistical process control of volumetric modulated arc therapy pre‐treatment verifications

Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: Interplay effects and mitigations

Comparative analysis of dose calculation algorithms for CyberKnife-based stereotactic radiotherapy in lung cancer

PUB114 Dose-Response Relationship for Safety and Efficacy Using Stereotactic Body Radiation Therapy for Centrally-Located Non-Small Cell Lung Cancer

Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC

Evaluation of Complexity and Deliverability of IMRT Treatment Plans for Breast Cancer.

Treatment plan complexity quantification for predicting gamma passing rates in patient‐specific quality assurance for stereotactic volumetric modulated arc therapy

Patient, tumour, and dosimetric factors influencing survival in non-small cell lung cancer patients treated with stereotactic ablative body radiotherapy

Isotoxic Investigation of 18F-FDG PET/CT-guided Dose Escalation with Intensity-Modulated Radiotherapy for LA-NSCLC

Long-term survival and failure patterns in inoperable early-stage non-small cell lung cancer following stereotactic body radiotherapy: a single-institution retrospective study

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by a Cyberknife stereotactic radiosurgery (SRS) system

Treatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performance

The impact of stereotactic body radiation therapy on the overall survival of patients diagnosed with early-stage non-small cell lung cancer

Analysis of Clinical and Dosimetric Factors Associated with Severe Acute Radiation Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemotherapy and Intensity-Modulated Radiotherapy

The efficacy and prognosis analysis after stereotactic body radiotherapy for multiple primary early-stage lung cancer

Partial Stereotactic Ablative Boost Radiotherapy in Bulky Non-Small Cell Lung Cancer: a Retrospective Study.